Belgian biopharmaceutical company UCB has announced plans to build a $2 billion biologics manufacturing facility in Gwinnett ...

Moving away from fed-batch has significant sustainability and cost-saving benefits, according to industry working groups.

A federal court for the District of Massachusetts blocked several changes made to the childhood vaccination schedule by ...

Automation in cell and gene therapy manufacturing promises lower costs, improved efficiency, and expanded access to ...